Literature DB >> 26161373

Stoma Creation After Surgery for Rectal Cancer: Temporary or Permanent?

Jung Wook Huh1.   

Abstract

Entities:  

Year:  2015        PMID: 26161373      PMCID: PMC4496456          DOI: 10.3393/ac.2015.31.3.82

Source DB:  PubMed          Journal:  Ann Coloproctol        ISSN: 2287-9714


× No keyword cloud information.
See Article on Page 98-102 In rectal cancer surgery, creation of diverting stomas can potentially minimize the fatal outcomes of anastomotic leakage, although it may not substantially decrease its incidence [12]. Several studies showing that a defunctioning stoma seems to be useful in preventing clinical anastomotic leakage and urgent reoperations in patients receiving a low anterior resection have been reported [13]; however, whether a diverting stoma itself can prevent anastomotic leakage independently is still a controversial issue. Rather, stoma creation in patients undergoing a low anterior resection after neoadjuvant chemoradiotherapy may be helpful for a patient's well-being because the predictable poor bowel function in the immediate postoperative period may be avoided. Up to a quarter of patients who undergo sphincter-saving surgery with a temporary stoma may consequently remain in the permanent stoma status, including nonreversal conditions or re-creation of another stoma after stoma-closure surgery [4567]. A review of the factors associated with a permanent stoma after a low anterior resection showed old age, anastomotic complications including leakage, radiation therapy, incurable local pelvic recurrence, systemic disease, and irreversible poor anal sphincter function after surgery to be significant [4567]. The benefits of a stoma in mitigating the potential complications due to anastomotic problems/pelvic sepsis in low rectal cancer must be balanced against the potential disadvantages of ostomy-related complications and of its subsequent closure procedure. Although making a decision on whether or not to create a stoma based on these factors only is hardly possible, this issue should be discussed preoperatively so that permanent-stoma-creating surgery may be selected according to patient's condition, especially in more elderly patients who are receiving radiotherapy and who have a poor anal sphincter function preoperatively.
  7 in total

Review 1.  Covering ileo- or colostomy in anterior resection for rectal carcinoma.

Authors:  Alessandro Montedori; Roberto Cirocchi; Eriberto Farinella; Francesco Sciannameo; Iosief Abraha
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

Review 2.  Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer.

Authors:  W S Tan; C L Tang; L Shi; K W Eu
Journal:  Br J Surg       Date:  2009-05       Impact factor: 6.939

3.  Characteristics and risk factors associated with permanent stomas after sphincter-saving resection for rectal cancer.

Authors:  Seok In Seo; Chang Sik Yu; Gwon Sik Kim; Jong Lyul Lee; Yong Sik Yoon; Chan Wook Kim; Seok-Byung Lim; Jin Cheon Kim
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

4.  Multivariate Analysis of Risk Factors Associated With the Nonreversal Ileostomy Following Sphincter-Preserving Surgery for Rectal Cancer.

Authors:  Young Ah Kim; Gil Jae Lee; Sung Won Park; Won-Suk Lee; Jeong-Heum Baek
Journal:  Ann Coloproctol       Date:  2015-06-30

5.  Risk factors for permanent stoma after low anterior resection for rectal cancer.

Authors:  Sang Woo Lim; Hun Jin Kim; Chang Hyun Kim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim
Journal:  Langenbecks Arch Surg       Date:  2012-12-09       Impact factor: 3.445

6.  Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial.

Authors:  Peter Matthiessen; Olof Hallböök; Jörgen Rutegård; Göran Simert; Rune Sjödahl
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

7.  Risk factors of permanent stomas in patients with rectal cancer after low anterior resection with temporary stomas.

Authors:  Chul Min Lee; Jung Wook Huh; Yoon Ah Park; Yong Beom Cho; Hee Cheol Kim; Seong Hyeon Yun; Woo Yong Lee; Ho-Kyung Chun
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.